S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in
NASDAQ:STAA

STAAR Surgical Stock Forecast, Price & News

$86.01
-4.63 (-5.11 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$82.47
Now: $86.01
$91.18
50-Day Range
$88.06
MA: $107.31
$126.48
52-Week Range
$23.20
Now: $86.01
$128.23
Volume779,892 shs
Average Volume903,879 shs
Market Capitalization$4.01 billion
P/E Ratio452.71
Dividend YieldN/A
Beta1.09
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers intraocular lenses (IOLs), including collamer material and silicone foldable IOLs, and nanoFLEX IOL that produces a clearer image, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision centers, surgical centers, hospitals, government facilities, and distributors primarily under the STAAR, EVO Visian ICL, Evolution in Visual Freedom, Visian, Collamer, CentraFLOW, AquaPORT, nanoFLEX, nanoPOINT, and Afinity trademarks. The company sells its products directly through its sales representatives in the United States, Japan, Spain, Germany, Canada, the United Kingdom, and Singapore, as well as through independent distributors in China, Korea, India, and internationally. STAAR Surgical Company was founded in 1982 and is based in Lake Forest, California.
STAAR Surgical logo

Headlines

Recap: Staar Surgical Q4 Earnings
February 24, 2021 |  benzinga.com
Why STAAR Surgical Stock Is Dropping Today
February 23, 2021 |  finance.yahoo.com
First Week of STAA February 2021 Options Trading
December 18, 2020 |  nasdaq.com
Is STAA A Good Stock To Buy Now?
December 14, 2020 |  finance.yahoo.com
STAAR Surgical EPS beats by $0.05, beats on revenue
November 4, 2020 |  seekingalpha.com
STAAR Surgical Reports Third Quarter 2020 Results
November 4, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies
SectorMedical
Current SymbolNASDAQ:STAA
CUSIP85231230
Phone626-303-7902
Employees550
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$150.18 million
Cash Flow$0.56 per share
Book Value$3.59 per share

Profitability

Net Income$14.05 million

Miscellaneous

Market Cap$4.01 billion
Next Earnings Date5/5/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.38 out of 5 stars

Medical Sector

667th out of 1,972 stocks

Ophthalmic Goods Industry

4th out of 8 stocks

Analyst Opinion: 1.3Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
$86.01
-4.63 (-5.11 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive STAA News and Ratings via Email

Sign-up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











STAAR Surgical (NASDAQ:STAA) Frequently Asked Questions

Is STAAR Surgical a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last year. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" STAAR Surgical stock.
View analyst ratings for STAAR Surgical
or view top-rated stocks.

What stocks does MarketBeat like better than STAAR Surgical?

Wall Street analysts have given STAAR Surgical a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but STAAR Surgical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting STAAR Surgical?

STAAR Surgical saw a increase in short interest during the month of February. As of February 12th, there was short interest totaling 2,630,000 shares, an increase of 39.9% from the January 28th total of 1,880,000 shares. Based on an average daily volume of 735,700 shares, the short-interest ratio is presently 3.6 days.
View STAAR Surgical's Short Interest
.

When is STAAR Surgical's next earnings date?

STAAR Surgical is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for STAAR Surgical
.

How were STAAR Surgical's earnings last quarter?

STAAR Surgical (NASDAQ:STAA) issued its earnings results on Tuesday, February, 23rd. The medical instruments supplier reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.05. STAAR Surgical had a trailing twelve-month return on equity of 8.99% and a net margin of 5.73%. During the same period last year, the firm earned $0.14 EPS.
View STAAR Surgical's earnings history
.

How has STAAR Surgical's stock price been impacted by Coronavirus (COVID-19)?

STAAR Surgical's stock was trading at $28.01 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, STAA shares have increased by 207.1% and is now trading at $86.01.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for STAA?

6 brokerages have issued 12-month target prices for STAAR Surgical's stock. Their forecasts range from $41.00 to $128.00. On average, they anticipate STAAR Surgical's share price to reach $68.50 in the next year. This suggests that the stock has a possible downside of 20.4%.
View analysts' price targets for STAAR Surgical
or view top-rated stocks among Wall Street analysts.

Who are STAAR Surgical's key executives?

STAAR Surgical's management team includes the following people:
  • Ms. Caren L. Mason, CEO, Pres & Director (Age 67, Pay $1.19M)
  • Dr. Keith Holliday, Chief Technology Officer (Age 58, Pay $597.39k)
  • Mr. Hans-Martin Blickensdoerfer, Sr. VP of Commercial Operations and Director of Markets - Europe & China (Age 56, Pay $561.19k)
  • Dr. Scott D. Barnes M.D., Chief Medical Officer (Age 59, Pay $681.32k)
  • Mr. Patrick F. Williams, Chief Financial Officer (Age 48)
  • Mr. Graydon C. Hansen, Sr. VP of Global Operations (Age 62)
  • Mr. Brian Moore, VP of Investor, Media Relations & Corp. Devel.
  • Mr. Samuel J. Gesten, Chief Legal Officer & Corp. Sec. (Age 59)
  • Mr. William Goodmen, VP of Global HR (Age 66)
  • Mr. James Francese, Sr. VP of Commercial Operations - North America & APAC (Age 57)

What is Caren Mason's approval rating as STAAR Surgical's CEO?

6 employees have rated STAAR Surgical CEO Caren Mason on Glassdoor.com. Caren Mason has an approval rating of 68% among STAAR Surgical's employees.

Who are some of STAAR Surgical's key competitors?

What other stocks do shareholders of STAAR Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STAAR Surgical investors own include Tesla (TSLA), NVIDIA (NVDA), PayPal (PYPL), The Walt Disney (DIS), CrowdStrike (CRWD), DocuSign (DOCU), Shopify (SHOP), The Trade Desk (TTD), Teladoc Health (TDOC) and Roku (ROKU).

What is STAAR Surgical's stock symbol?

STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."

Who are STAAR Surgical's major shareholders?

STAAR Surgical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.62%), Baillie Gifford & Co. (5.09%), Morgan Stanley (1.36%), Northern Trust Corp (1.23%), Artisan Partners Limited Partnership (1.08%) and Norges Bank (0.99%). Company insiders that own STAAR Surgical stock include Broadwood Partners, LP, Caren L Mason, Deborah J Andrews, Graydon C Hansen, Hans-Martin Blickensdoerfer, Jon K Hayashida, Keith Holliday, Samuel J Gesten and Scott D Barnes.
View institutional ownership trends for STAAR Surgical
.

Which institutional investors are selling STAAR Surgical stock?

STAA stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Defender Capital LLC., Pura Vida Investments LLC, Royce & Associates LP, Acuitas Investments LLC, Nuveen Asset Management LLC, UBS Asset Management Americas Inc., and Dimensional Fund Advisors LP. Company insiders that have sold STAAR Surgical company stock in the last year include Broadwood Partners, LP, Caren L Mason, Hans-Martin Blickensdoerfer, Jon K Hayashida, Keith Holliday, and Samuel J Gesten.
View insider buying and selling activity for STAAR Surgical
or view top insider-selling stocks.

Which institutional investors are buying STAAR Surgical stock?

STAA stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, APEIRON CAPITAL Ltd, Canada Pension Plan Investment Board, BlackRock Inc., Morgan Stanley, JPMorgan Chase & Co., KAMES CAPITAL plc, and Price T Rowe Associates Inc. MD.
View insider buying and selling activity for STAAR Surgical
or or view top insider-buying stocks.

How do I buy shares of STAAR Surgical?

Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is STAAR Surgical's stock price today?

One share of STAA stock can currently be purchased for approximately $86.01.

How much money does STAAR Surgical make?

STAAR Surgical has a market capitalization of $4.01 billion and generates $150.18 million in revenue each year. The medical instruments supplier earns $14.05 million in net income (profit) each year or $0.46 on an earnings per share basis.

How many employees does STAAR Surgical have?

STAAR Surgical employs 550 workers across the globe.

What is STAAR Surgical's official website?

The official website for STAAR Surgical is www.staar.com.

Where are STAAR Surgical's headquarters?

STAAR Surgical is headquartered at 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630.

How can I contact STAAR Surgical?

STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at [email protected]


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.